Instrumento Inactivo

Acciones Oncothyreon Inc (USA) Nasdaq

Acciones

Duración

Período

Estilo

Cascadian Therapeutics Announces 2018 Outlook and Recent Progress	04/01/18
Cascadian Therapeutics Receives Pediatric Investigation Plan Waiver from the European Medicines Agency	02/01/18
Cascadian Therapeutics Added to the Nasdaq Biotechnology Index	13/12/17
Prolonged Progression-Free Survival Reinforces Tucatinib’s Potential for Patients with Advanced HER2+ Metastatic Breast Cancer	07/12/17
Cascadian Therapeutics Reports Third Quarter 2017 Financial Results	08/11/17

Sector

	Varia. 1 de ene.	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+20,03 %	126 mil M
REGENERON PHARMACEUTICALS, INC.	+23,61 %	118 mil M
ARGENX SE	+23,26 %	27,87 mil M
BIONTECH SE	-18,07 %	20,95 mil M
GENMAB A/S	-15,13 %	16,92 mil M
BEIGENE, LTD.	-14,81 %	16,18 mil M
NEUROCRINE BIOSCIENCES, INC.	+9,78 %	14,84 mil M
WUXI APPTEC CO., LTD.	-46,10 %	14,79 mil M
SAREPTA THERAPEUTICS, INC.	+52,34 %	14,08 mil M